Sisram Medical's book value per share for the quarter that ended in Dec. 2025 was $1.03.
During the past 12 months, Sisram Medical's average Book Value Per Share Growth Rate was 3.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 3.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 24.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Sisram Medical was 120.60% per year. The lowest was 3.60% per year. And the median was 7.70% per year.
Sisram Medical's current price is $0.43835. Its book value per share for the quarter that ended in Dec. 2025 was $1.03. Hence, today's PB Ratio of Sisram Medical is 0.43.
During the past 12 years, the highest P/B Ratio of Sisram Medical was 11.49. The lowest was 0.28. And the median was 0.79.
Good Sign:
Sisram Medical Ltd stock PB Ratio (=0.29) is close to 10-year low of 0.28.
Sisram Medical (OTCPK:SRAMF) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Sisram Medical Book Value per Share Related Terms
Sisram Medical Book Value per Share Historical Data
* Premium members only.
The historical data trend for Sisram Medical's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SRAMF vs ABT, SYK, MDT: Book Value per Share Comparison
For the Medical Devices subindustry, Sisram Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sisram Medical PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sisram Medical's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sisram Medical (SRAMF) has a Book Value per Share of $1.03 as of Dec. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Sisram Medical and its competitors.
Is Sisram Medical's Book Value per Share too high?
Sisram Medical's current Book Value per Share is $1.03. Overall, Sisram Medical has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's Book Value per Share compare to ABT and SYK?
Sisram Medical's Book Value per Share of $1.03 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Devices & Instruments company?
A good Book Value per Share depends on the Medical Devices & Instruments industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Sisram Medical and its competitors. Sisram Medical's current Book Value per Share is $1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.98, compared to a current price of $0.44 — trading 55.3% below its estimated fair value. The current Book Value per Share is $1.03. Sisram Medical's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current Book Value per Share is $1.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sisram Medical (SRAMF) Overvalued in 2026?
Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued.
The current stock price of $0.44 is trading 55.3% below its estimated GF Value™ of $0.98.
GuruFocus considers Sisram Medical to be Significantly Undervalued.
Key valuation signals for SRAMF:
Book Value per Share: $1.03
GF Value™: $0.98 vs. price of $0.44 (55.3% below fair value)
No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
57GF Score
Get the complete analysis for SRAMF
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRAMF has been successfully added to your 
